Leaguer Venture Investment
Room B307 (No. 76 mailbox), Building of Research Institute of Tsinghua University, South of High-tech Zone, Nanshan District, Shenzhen, Guangdong, 518057, China
Overview
Shenzhen Leaguer Venture Capital Co., Ltd. is a high-tech venture capital company founded by Research Institute of Tsinghua University in Shenzhen (RITS) in August 1999. Its current registered capital is RMB 333.3333 million, managing assets amounted to RMB 1.5 billion. With solid capital strength, rich experience of investment and flexible mechanism, Leaguer VC has invested more than 50 portfolio companies, ranging from IT, new material, medicine, electronics to optomechatronics and hi-tech incubators, etc. The average IRR for the current investments exceeds 30%. Leaguer VC has successfully finished its fund-raising of RMB 160 million in 2009 and set up fund management companies and venture capital companies located in Changzhou and Wuxi.
- Total investments
- 3
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 1
Sector focus
- Finance
- Venture Capital
Investment portfolio
- NeuCyte
Led · Series A · May 2018
NeuCyte develops the SynFire® in vitro CNS drug discovery platform using neuronal cells generated from iPSCs derived from healthy or diseased individuals. The company’s proprietary neuronal reprogramming technology, developed in the labs of Dr. Thomas Südhof and Dr. Marius Wernig at Stanford, produces large quantities of pure populations of specific neuronal subtypes. SynFire cells can be mixed and matched and co-cultured with astroglia, enabling phenotypic and target-based drug screens in a human context. NeuCyte is focused on identifying novel drug targets for Fragile X Syndrome (FXS) and other genetically defined neurological disorders. The company is led by co-founder and CEO Jonathan Davila and co-founder and President Tao Huang, and is based in Sunnyvale, California. Financially, the business has raised over $8M to date.
- Oben
Participated · Equity · Nov 2016
Oben builds technology that converts a 2D photo plus a simple voice recording into a realistic 3D virtual head or avatar for VR and AR environments. The company emphasizes translating a user's character, personality, and individuality into realistic avatars rather than cartoon-like representations. Oben plans to launch its virtual self product in Q1 2017 and says the funds will be used for rapid product development, hiring more scientists, and identifying new partnerships. It positions its avatars to enable more social and shared experiences in VR, including personalized music and entertainment. Oben is a portfolio company of the HTC Vive X accelerator and was selected for the program in July 2016. The company was founded in 2014, is based in Pasadena, CA, and has about 20 employees. Prior to this raise, Oben had previously raised $150,000.
- ActBlue
Participated · Equity · Sep 2010
Anhui ActBlue develops post-treatment systems for diesel engines. Its products meet EU standards and are used in heavy-duty and light trucks, pickups and public transportation vehicles. The company is based in China. It received a RMB150M equity investment to support its development. The financing proceeds are intended to fund product and company development. No operating metrics or past financing details are provided in the article.
Team
Zhang Shulue
Partner